The carotenoid compound crocetin has been hypothesized to enhance the diffu
sion of O-2 through plasma, and observations in the rat and rabbit have rev
ealed improvement in arterial Po-2 when crocetin is given. To determine whe
ther crocetin enhances diffusion of O-2 between alveolar gas and the red bl
ood cell in the pulmonary capillary in vivo, five foxhounds, two previously
subjected to sham and three to actual lobectomy or pneumonectomy, were stu
died while breathing 14% O-2, at rest and during moderate and heavy exercis
e before and within 10 min after injection of a single dose of crocetin as
the trans isomer of sodium crocetinate (TSC) at 100 mu g/kg iv. This dose i
s equivalent to that used in previous studies and would yield an initial pl
asma concentration of 0.7-1.0 mu g/ml. Ventilation-perfusion inequality and
pulmonary diffusion limitation were assessed by the multiple inert gas eli
mination technique in concert with conventional measurements of arterial an
d mixed venous O-2 and CO2. TSC had no effect on ventilation, cardiac outpu
t, O-2 consumption, arterial Po-2/saturation, or pulmonary O-2 diffusing ca
pacity. There were minor reductions in ventilation-perfusion mismatching (l
ogarithm of the standard deviation of perfusion fell from 0.48 to 0.43, P =
0.001) and in CO, output and respiratory exchange ratio (P = 0.05), which
may have been due to TSC or to persisting effects of the first exercise bou
t. Spectrophotometry revealed that TSC disappeared from plasma with a half
time of similar to 10 min. We conclude that, in this model of extensive pul
monary O-2 diffusion Limitation, TSC as given has no effect on O-2 exchange
or transport. Whether the original hypothesis is invalid, thy dose of TSC
was too low, or plasma diffusion of O-2 is not rate Limiting without TSC ca
nnot be discerned from the present study.